@article{bruera:inserm-00817083, TITLE = {{Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx).}}, AUTHOR = {Bruera, Gemma and Cannita, Katia and Di Giacomo, Daniela and Lamy, Aude and Fr{\'e}bourg, Thierry and Sabourin, Jean Christophe and Tosi, Mario and Alesse, Edoardo and Ficorella, Corrado and Ricevuto, Enrico}, URL = {https://inserm.hal.science/inserm-00817083}, JOURNAL = {{BMC Medicine}}, PUBLISHER = {{BioMed Central}}, VOLUME = {11}, NUMBER = {1}, PAGES = {59}, YEAR = {2013}, MONTH = Mar, DOI = {10.1186/1741-7015-11-59}, KEYWORDS = {KRAS mutation ; Kras c.35 G > A mutation ; triplet chemotherapy plus bevacizumab ; metastatic colorectal cancer ; FIr-B/FOx}, PDF = {https://inserm.hal.science/inserm-00817083/file/1741-7015-11-59.pdf}, HAL_ID = {inserm-00817083}, HAL_VERSION = {v1}, }